Our study confirmed key proteins (PCSK9, ANGPTL3, LPA), identified potential novel targets (GSTA1, GSTA3, EPPK1, PECR, and PLA2G15), and strengthened evidence for CELSR2 and GAS6 in dyslipidaemia. This evidence concerns the gene LPA and inherited lipid metabolism disorder.